255 related articles for article (PubMed ID: 28273426)
1. A primer on current progress in cardiac fibrosis.
Al Hattab D; Czubryt MP
Can J Physiol Pharmacol; 2017 Oct; 95(10):1091-1099. PubMed ID: 28273426
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
[TBL] [Abstract][Full Text] [Related]
3. Properties and Immune Function of Cardiac Fibroblasts.
Furtado MB; Hasham M
Adv Exp Med Biol; 2017; 1003():35-70. PubMed ID: 28667553
[TBL] [Abstract][Full Text] [Related]
4. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
Dobaczewski M; de Haan JJ; Frangogiannis NG
J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
[TBL] [Abstract][Full Text] [Related]
5. Temporal alterations in cardiac fibroblast function following induction of pressure overload.
Stewart JA; Massey EP; Fix C; Zhu J; Goldsmith EC; Carver W
Cell Tissue Res; 2010 Apr; 340(1):117-26. PubMed ID: 20217135
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibroblast-matrix interactions and potential therapeutic targets.
Goldsmith EC; Bradshaw AD; Zile MR; Spinale FG
J Mol Cell Cardiol; 2014 May; 70():92-9. PubMed ID: 24472826
[TBL] [Abstract][Full Text] [Related]
7. Cardiac fibrosis.
Frangogiannis NG
Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Fibrosis: The Fibroblast Awakens.
Travers JG; Kamal FA; Robbins J; Yutzey KE; Blaxall BC
Circ Res; 2016 Mar; 118(6):1021-40. PubMed ID: 26987915
[TBL] [Abstract][Full Text] [Related]
9. Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate.
Song J; Meng Y; Wang M; Li L; Liu Z; Zheng K; Wu L; Liu B; Hou F; Li A
Pharmacol Res; 2020 Jul; 157():104845. PubMed ID: 32353588
[TBL] [Abstract][Full Text] [Related]
10. Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.
Weber KT; Sun Y; Gerling IC; Guntaka RV
Am J Hypertens; 2017 Nov; 30(11):1049-1052. PubMed ID: 28379281
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Alcohol Exposure Causes Adverse Cardiac Extracellular Matrix Changes and Dysfunction in Neonatal Mice.
Ninh VK; El Hajj EC; Mouton AJ; Gardner JD
Cardiovasc Toxicol; 2019 Oct; 19(5):389-400. PubMed ID: 30684169
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Fibrosis and Fibroblasts.
Kurose H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359886
[TBL] [Abstract][Full Text] [Related]
13. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
14. GHSR deficiency exacerbates cardiac fibrosis: role in macrophage inflammasome activation and myofibroblast differentiation.
Wang M; Qian L; Li J; Ming H; Fang L; Li Y; Zhang M; Xu Y; Ban Y; Zhang W; Zhang Y; Liu Y; Wang N
Cardiovasc Res; 2020 Nov; 116(13):2091-2102. PubMed ID: 31790138
[TBL] [Abstract][Full Text] [Related]
15. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
Schimmel K; Jung M; Foinquinos A; José GS; Beaumont J; Bock K; Grote-Levi L; Xiao K; Bär C; Pfanne A; Just A; Zimmer K; Ngoy S; López B; Ravassa S; Samolovac S; Janssen-Peters H; Remke J; Scherf K; Dangwal S; Piccoli MT; Kleemiss F; Kreutzer FP; Kenneweg F; Leonardy J; Hobuß L; Santer L; Do QT; Geffers R; Braesen JH; Schmitz J; Brandenberger C; Müller DN; Wilck N; Kaever V; Bähre H; Batkai S; Fiedler J; Alexander KM; Wertheim BM; Fisch S; Liao R; Diez J; González A; Thum T
Circulation; 2020 Mar; 141(9):751-767. PubMed ID: 31948273
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of myocardial fibrosis.
de Jong S; van Veen TA; de Bakker JM; Vos MA; van Rijen HV
J Cardiovasc Pharmacol; 2011 May; 57(5):522-35. PubMed ID: 21423029
[TBL] [Abstract][Full Text] [Related]
17. Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes.
Hutchinson KR; Lord CK; West TA; Stewart JA
PLoS One; 2013; 8(8):e72080. PubMed ID: 23991045
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of fibrosis in genetic cardiomyopathies.
Eijgenraam TR; Silljé HHW; de Boer RA
Trends Cardiovasc Med; 2020 Aug; 30(6):353-361. PubMed ID: 31585768
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis.
Leerink JM; van de Ruit M; Feijen EAM; Kremer LCM; Mavinkurve-Groothuis AMC; Pinto YM; Creemers EE; Kok WEM
J Mol Med (Berl); 2021 Sep; 99(9):1195-1207. PubMed ID: 34052857
[TBL] [Abstract][Full Text] [Related]
20. Modeling Cardiac Fibrosis in Mice: (Myo)Fibroblast Phenotype After Ischemia.
Fraccarollo D; Galuppo P; Bauersachs J
Methods Mol Biol; 2017; 1627():123-137. PubMed ID: 28836199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
